Cytomegalovirus and recurrent idiopathic membranoproliferative glomerulonephritis type 1: Cause or consequence? [2]

Transplantation

Volumn 83, Issue 4, 2007, Pages 523-524

  Wenderfer, Scott E ^a   Swinford, Rita D ^a   Mauiyyedi, Shamila ^a   Witte, David P ^b   Braun, Michael C ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CREATININE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; GRAFT FAILURE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVING DONOR; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHRECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; SERODIAGNOSIS; TREATMENT FAILURE; VIRUS REACTIVATION; VIRUS SHEDDING; ALLOTRANSPLANTATION; CYTOMEGALIC INCLUSION BODY DISEASE; VIROLOGY;

CYTOMEGALOVIRUS INFECTIONS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY TRANSPLANTATION; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947543917     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251362.75382.18     Document Type: Letter

References (7)

1. Nowicki MJ, Welch TR, Ahmad N, et al. Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis. Pediatr Nephrol 1995; 9(1): 16.
2. Andresdottir MB, Assmann KJ, Hilbrands LB, Wetzels JF. Type I membranoproliferative glomerulonephritis in a renal allograft: A recurrence induced by a cytomegalovirus infection? Am J Kidney Dis 2000; 35(2): E6.
3. Birk PE, Chavers BM. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol 1997; 8(11): 1801.
4. Abecassis MM, Koffron AJ, Buckingham M, et al. Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for development of disease and should PCR be used to guide antiviral therapy? Transplant Proc 29 (1-2): 800, 1997.
5. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5(2): 218.
6. Buller RS, Bailey TC, Ettinger NA, et al. Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. J Clin Microbiol 1992; 30(10): 2620.
7. Uj M, Szucs G, Nagy J, Trinn C. Antibodies to viruses of the herpes group in glomerulonephritis of membranous, membranoproliferative and IgA types. Int Urol Nephrol 1988; 20(2): 201.